• Entinostat (MS-275) HDAC Research Workflows

  2026-08-12

  Entinostat (MS-275) combines class I HDAC1/3 selectivity with practical utility across cancer, retinoblastoma, and axolotl regeneration models. This workflow-focused guide covers assay design, formulation, quantitative readouts, and troubleshooting so researchers can separate epigenetic target engagement from nonspecific toxicity.

• Metformin HCl in Vocal Fold Fibrosis Research

  2026-08-12

  Explore how Metformin Hydrochloride (Metformin HCl) can be used to interrogate AMPK-dependent antifibrotic mechanisms in vocal fold injury models. This guide translates rabbit and fibroblast evidence into assay design, formulation, controls, and interpretation decisions.

• Caspase-4 Colorimetric Assay Kit Workflow

  2026-08-11

  Turn LEVD-dependent caspase-4 activity into a practical readout for pyroptosis, inflammasome signaling, and treatment-response studies. This workflow pairs the Caspase-4 Colorimetric Assay Kit with organelle-targeted cancer research while clearly separating caspase-4 activation from general cell death.

• EZ Cap™ Human PTEN mRNA: Translational Strategy

  2026-08-11

  A mechanistic and strategic guide to using EZ Cap™ Human PTEN mRNA (ψUTP) as an in vitro transcribed mRNA tool for restoring PTEN biology, interrogating PI3K/Akt signaling, and designing translational cancer research programs around therapeutic resistance.

• PTEN mRNA Nanoparticles Reverse Trastuzumab Resistance

  2026-08-10

  Dong and colleagues developed tumor-microenvironment-responsive nanoparticles for systemic PTEN mRNA delivery in trastuzumab-resistant HER2-positive breast cancer. The study links conditional nanoparticle uptake and restored PTEN expression to PI3K/Akt signaling pathway inhibition, providing a mechanistically focused strategy for re-sensitizing tumors to trastuzumab.

• ω-Agatoxin IVA TFA: Assay Design Guide

  2026-08-09

  Learn how ω-Agatoxin IVA TFA (SKU C8722) can improve mechanistic interpretation in neuronal calcium, synaptic transmission, and viability workflows. This scenario-based guide explains concentration selection, Cav2.1 subtype interpretation, storage, and vendor-selection criteria using current structural evidence.

• ECL Western Blotting Substrate: Workflow Guide

  2026-08-08

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for chemiluminescent Western blot assays. It is intended for HRP-mediated immunoblot imaging with film or CCD systems, not for fluorescent or radioisotopic detection workflows.

• ω-Agatoxin IVA and Cortical Excitotoxicity

  2026-08-07

  Lustig, Ahern, and Greenberg tested whether selective P/Q-type calcium-channel blockade could protect cortical neurons from excitotoxic injury. Their negative result shows that inhibiting toxin-sensitive calcium channels or presynaptic glutamate release is not, by itself, sufficient to prevent acute neuronal damage in this culture model.

• AICAR and Mitophagy: Precision Tools for Metabolic Stress Re

  2026-08-07

  Explore how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) enables targeted dissection of AMPK-dependent mitophagy for metabolic disease research. This article uniquely bridges recent mechanistic insights to practical assay optimization.

• 10 mM dNTP Mixture: Precision DNA Synthesis for Modern Workf

  2026-08-06

  APExBIO’s 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture stands as a benchmark DNA synthesis reagent, enabling high-fidelity PCR, qPCR, and sequencing with exceptional reproducibility. Its equimolar, pH-stabilized formulation simplifies complex experimental designs and empowers cutting-edge nucleic acid delivery research.

• Metformin Hydrochloride: Protocol Innovations for Fibrosis &

  2026-08-06

  Metformin Hydrochloride (Metformin HCl) is redefining fibrosis and metabolic pathway research by enabling precise AMPK pathway modulation and inhibition of hepatic gluconeogenesis. This guide bridges cutting-edge findings with actionable protocols, troubleshooting insights, and comparative applications for advanced bench workflows.

• Berberrubine's Role in NAFLD: Glucose, Lipid, and Microbiota

  2026-08-05

  Yang et al. demonstrate that berberrubine, a principal metabolite of berberine, alleviates non-alcoholic fatty liver disease (NAFLD) by modulating glucose and lipid metabolism and restoring gut microbiota balance. This research provides mechanistic insights with translational potential for metabolic liver disease intervention.

• BKT140 (BL-8040): Transforming CXCR4-Driven Cancer Research

  2026-08-05

  Discover how BKT140 (BL-8040), a potent CXCR4 antagonist, is reshaping the landscape of tumor progression and stem cell mobilization studies. This article delivers in-depth insight into its mechanism, assay optimization, and evolving role in oncology research.

• ω-Agatoxin IVA Suppresses Seizures and Modulates BDNF/Caspas

  2026-08-04

  This study demonstrates that the P/Q-type calcium channel blocker ω-Agatoxin IVA significantly delays seizure onset and modulates neuroprotective markers in a rat epilepsy model. The findings highlight a mechanistically distinct approach to anticonvulsant and neuroprotective research, with translational implications for synaptic transmission and neuronal survival.

• DeferoxamineB in Cancer Research: Protocols, Workflows, and

  2026-08-04

  Deferoxamine (DeferoxamineB) enables precision iron chelation and the fine-tuning of regulated cell death in experimental oncology, with applications spanning ferroptosis, autophagy, and apoptosis assays. This guide distills the latest workflow enhancements, troubleshooting strategies, and emerging cross-domain insights, helping researchers maximize both assay reliability and translational impact.

8413 records 3/561 page Previous Next 12345 下5页 Last page